EMEA-001006-PIP05-18

Key facts

Invented name
  • Ofev
  • Vargatef
Active substance
nintedanib
Therapeutic area
  • Oncology
  • Pneumology-allergology
Decision number
P/0150/2019
PIP number
EMEA-001006-PIP05-18
Pharmaceutical form(s)
Capsule, soft
Condition(s) / indication(s)
Treatment of fibrosing Interstitial Lung Diseases (ILD)
Route(s) of administration
Oral use
Contact for public enquiries
Boehringer Ingelheim International GmbH
Tel. +49 6132 778271
E-mail: paediatrics@boehringer-ingelheim.com
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating